drugset

drugset / Trial / NCT00455364

Voriconazole as Prophylactic Therapy in Lung Transplant Recipients

NCT00455364 ↗

Phase 4 Terminated 20 enrolled University of Chicago Pfizer · collab

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to compare the safety and efficacy of Voriconazole with Itraconazole following lung transplantation.

Timeline

Start: 2007-04
Primary completion: 2007-04
Completion: 2007-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Voriconazole	Small molecule	200 mg	Oral

Indications